RSI has developed patent pending technology titled Modified Alginate Hydrogels for Therapeutic Agents (USPTO Pending #15/606/769 & PCT/US/17/34748) and a second filing titled Modified Carbohydrates, Compositions Comprising the Same, and Methods of Making and Using the Same (PCT/US/17/40283). These filings are extensive and describe a method of oral delivery that revolutionizes the way veterinary medicines are delivered orally and protected from damaging stomach acids and enzymatic actions
A wide variety of medicines must be given to large and small animals on a regular basis, and due to the taste or smell of the medicine, animals often reject it. Cats in particular are not easily given pills of any kind.
RSI’s patented hydrogel technology lends itself to improving the delivery of animal health applications. The animal health applications cover large and small animals such as household pets, cats and dogs making up the majority of this group. The hydrogel technology is also well suited for larger farm animals such as horses, cows, pigs and sheep.
RSI’s patented hydrogels, which are tasteless and odorless, can contain a wide range of medications and dietary supplements, and be embedded in a “treat” or other food form palatable to the animal. This hydrogel technology is adjustable to accommodate different drug dosages based on veterinary recommendations related to animal weight.